Why the study?
Does dialysis impair the anticoagulant effect of heparin in vitro?
Does dialysis impair the anticoagulant effect of heparin in vitro?
The anticoagulant effect of heparin is impaired during in vitro dialysis due to the influx of calcium, magnesium, and acetate ions from the dialysate, rather than heparin loss.
Answers are grounded in this paper and cite their sources.
May reduce heparin effect during in vitro dialysis via ion influx; leaves open clinical relevance in hemodialysis.
Dialysis of blood and plasma was performed in vitro, in a 'mini-Kill' dialyser as well as in dialysis bags. A marked shortening of the thrombin-clotting time was observed, indicating fall in heparin anticoagulant effect. The concentration of heparin, however, as measured by polybrene titration, was substantially less reduced. Fibrin formation, as evidenced by the ethanol gelation test, occurred more often in the dialysed than in the control plasma. In conclusion, the discrepancy between concentration and anticoagulant effect of heparin could be partly explained by influx from the dialysate of calcium, magnesium, and acetate ions. The fibrin-polymerizing effect of these ions was confirmed by a shortening of the clotting time with Reptilase, a proteolytic enzyme not influenced by thrombin inhibitors such as heparin. In addition, liberation of platelet factor 4 may be responsible for some reduction in antithrombin activity of heparin. No evidence of heparin being dialysed or adhering to the dialysis membrane was found.
No takes yet. Share an insight, caveat, or question.
Bjørnson et al. (1976) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: